OP Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.9M Sell
212,727
-16,194
-7% -$944K 0.13% 107
2025
Q4
$12.3M Sell
228,921
-8,273
-3% -$398K 0.15% 111
2025
Q3
$10.7M Buy
237,194
+3,111
+1% +$145K 0.14% 123
2025
Q2
$10.8M Sell
234,083
-71,182
-23% -$3.49M 0.16% 111
2025
Q1
$18.6M Buy
+305,265
New +$17.8M 0.3% 58

Other funds holding BMY

OP Asset Management's BMY Position: Q1 2026 in Review

OP Asset Management reduced its Bristol-Myers Squibb (BMY) stake by 7.1% in Q1 2026, selling an estimated $944K and leaving 212,727 shares worth $12.9M. The position accounts for 0.13% of the portfolio, ranked #107.

OP Asset Management first reported a position in BMY in Q1 2025 and has held it in 5 quarters since. The position peaked at $18.6M in Q1 2025. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • OP Asset Management held 212,727 shares of Bristol-Myers Squibb worth $12.9M as of Q1 2026.
  • OP Asset Management sold 16,194 Bristol-Myers Squibb shares in Q1 2026, an estimated $944K.
  • Bristol-Myers Squibb made up 0.13% of OP Asset Management's portfolio in Q1 2026, its #107 holding.
  • OP Asset Management first reported a position in Bristol-Myers Squibb in Q1 2025 and has held it in 5 quarters since.
  • OP Asset Management's Bristol-Myers Squibb position peaked at $18.6M in Q1 2025.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on OP Asset Management's 13F filing for Q1 2026, filed 9 Apr 2026.